A UK market access summit convened by IQVIA brought together pharma and NHS leaders to look at how working more closely – including more outcomes-based deals – could help UK life sciences ...

GEN subsequently asked a number of biotech scientists and CEOs, both within and without the U.K. and the EU, for their opinion on the potential impact of Brexit on pharma, life science, and ...

Brexit may affect the cost of medicines and hit UK pharmaceutical investment, a Commons committee head has warned. Rachel Reeves, who chairs the Business, Energy and Industrial Strategy (BEIS ...

Brexit and the Healthcare Industry - Implications for Pharma, Q3 2018: Key Factors to Impact the Post-Brexit UK Healthcare Industry Providing Respondent Mix by Region and Seniority Level ...

The impact of Brexit on the pharmaceutical industry has yet to be determined, but some fear that Brexit will cause the UK to lag behind in the biosimilar sphere in particular.

Infiniti, a leading market intelligence solutions provider, has announced the launch of their latest article on illuminating the impact of Brexit on Europe’s pharmaceutical industry. Brexit can ...

As a result, pharmaceutical and medical devices companies should treat this development cautiously, and already be addressing their post-Brexit solutions.

UK and European pharma organisations have called for urgent progress in Brexit negotiations covering medicines’ regulation, stressing the importance of cooperation between UK and EU.

The volatility has enlivened what has been a slow year for biotech and pharma stocks, which took a hit in the first weeks of 2016.

Rachel Reeves says uncertainty about Brexit is "very concerning" for the UK pharmaceutical industry.

Brexit may affect the cost of medicines and hit UK pharmaceutical investment, a Commons committee head has warned. Rachel Reeves, who chairs the Business, Energy and Industrial Strategy (BEIS ...